Local gene delivery of sPD-1 can enhances the anti-tumor effects of other local gene therapeutic agents probably via reducing the inhibitory effects of PD-1/PD-L1 interaction upregulated after tumor-specific T cells activation (163, 166–174). The gene discussed is HOXD13; the disease is neoplasm.